Braidwell LP Viking Therapeutics, Inc. Transaction History
Braidwell LP
- $1.63 Billion
- Q1 2025
A detailed history of Braidwell LP transactions in Viking Therapeutics, Inc. stock. As of the latest transaction made, Braidwell LP holds 1,435,955 shares of VKTX stock, worth $39.6 Million. This represents 2.13% of its overall portfolio holdings.
Number of Shares
1,435,955
Previous 1,479,666
2.95%
Holding current value
$39.6 Million
Previous $59.5 Million
41.76%
% of portfolio
2.13%
Previous 3.34%
Shares
5 transactions
Others Institutions Holding VKTX
# of Institutions
432Shares Held
65.2MCall Options Held
8.28MPut Options Held
3.39M-
Vanguard Group Inc Valley Forge, PA10.2MShares$280 Million0.0% of portfolio
-
Black Rock Inc. New York, NY6.03MShares$166 Million0.01% of portfolio
-
State Street Corp Boston, MA4.06MShares$112 Million0.0% of portfolio
-
Jpmorgan Chase & CO New York, NY3.13MShares$86.3 Million0.01% of portfolio
-
Morgan Stanley New York, NY3.12MShares$86.1 Million0.01% of portfolio
About Viking Therapeutics, Inc.
- Ticker VKTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,688,496
- Market Cap $2.12B
- Description
- Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...